• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Effect of age upon the induction and maintenance of anticoagulation with warfarin.年龄对华法林抗凝诱导及维持的影响。
Postgrad Med J. 1995 Mar;71(833):153-5. doi: 10.1136/pgmj.71.833.153.
2
Outcomes of warfarin therapy managed by pharmacists via hospital anticoagulation clinic versus online anticoagulation clinic.药剂师通过医院抗凝门诊与在线抗凝门诊管理华法林治疗的结果。
Int J Clin Pharm. 2018 Oct;40(5):1072-1077. doi: 10.1007/s11096-018-0674-0. Epub 2018 Jun 28.
3
Effect of heart failure exacerbations on anticoagulation: a prospective, observational, pilot cohort study.心力衰竭恶化对抗凝的影响:一项前瞻性、观察性、试点队列研究。
Clin Ther. 2010 Mar;32(3):506-14. doi: 10.1016/j.clinthera.2010.03.001.
4
Evaluation of pharmacist-based compared to doctor-based anticoagulation management in Qatar.基于药师的与基于医生的抗凝管理在卡塔尔的比较评估。
J Eval Clin Pract. 2016 Jun;22(3):433-8. doi: 10.1111/jep.12504. Epub 2016 Jan 14.
5
Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.华法林治疗稳定患者亚治疗剂量抗凝的血栓栓塞后果:低国际标准化比值(INR)研究
Pharmacotherapy. 2008 Aug;28(8):960-7. doi: 10.1592/phco.28.8.960.
6
International normalized ratio stabilization in newly initiated warfarin patients with nonvalvular atrial fibrillation.非瓣膜性心房颤动初治华法林患者的国际标准化比值稳定情况
Curr Med Res Opin. 2014 Dec;30(12):2437-42. doi: 10.1185/03007995.2014.957822. Epub 2014 Sep 2.
7
The duration of anticoagulation bridging therapy in clinical practice may significantly exceed that observed in clinical trials.临床实践中抗凝桥接治疗的持续时间可能显著超过临床试验中观察到的时间。
J Thromb Thrombolysis. 2007 Apr;23(2):107-13. doi: 10.1007/s11239-006-9023-6.
8
Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice.心房颤动患者卒中的抗凝预防:实际应用中的有效性。
CMAJ. 1999 Sep 7;161(5):493-7.
9
Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.药师管理的住院患者抗凝治疗启动和滴定服务的疗效和安全性。
J Clin Pharm Ther. 2011 Oct;36(5):585-91. doi: 10.1111/j.1365-2710.2010.01216.x. Epub 2010 Nov 12.
10
Anticoagulation-related outcomes in patients receiving warfarin after starting levofloxacin or gatifloxacin.开始使用左氧氟沙星或加替沙星后接受华法林治疗的患者的抗凝相关结局。
Pharmacotherapy. 2006 Oct;26(10):1446-52. doi: 10.1592/phco.26.10.1446.

引用本文的文献

1
The future prospects of pharmacogenetics in oral anticoagulation therapy.药物遗传学在口服抗凝治疗中的未来前景。
Br J Clin Pharmacol. 2006 Jun;61(6):746-51. doi: 10.1111/j.1365-2125.2006.02679.x.
2
Racial background is a determinant factor in the maintenance dosage of warfarin.
Int J Hematol. 2003 Jul;78(1):84-6. doi: 10.1007/BF02983247.
3
Use of oral anticoagulants in older patients.
Drugs Aging. 2000 Jun;16(6):409-35. doi: 10.2165/00002512-200016060-00003.
4
Audit of anticoagulant therapy.抗凝治疗审计。
J Clin Pathol. 1996 Jan;49(1):5-9. doi: 10.1136/jcp.49.1.5.

本文引用的文献

1
Survey of use of anticoagulation in patients with atrial fibrillation.心房颤动患者抗凝治疗使用情况调查。
BMJ. 1993 Oct 23;307(6911):1045. doi: 10.1136/bmj.307.6911.1045.
2
Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.不同强度的口服抗凝治疗在近端静脉血栓形成治疗中的应用
N Engl J Med. 1982 Dec 30;307(27):1676-81. doi: 10.1056/NEJM198212303072704.
3
Flexible induction dose regimen for warfarin and prediction of maintenance dose.华法林的灵活诱导剂量方案及维持剂量预测
Br Med J (Clin Res Ed). 1984 Apr 28;288(6426):1268-70. doi: 10.1136/bmj.288.6426.1268.
4
Warfarin therapy: need for a protocol?华法林治疗:需要一个方案吗?
Br J Clin Pract. 1988 May;42(5):196-7.
5
Long-term oral anticoagulant therapy in elderly patients.老年患者的长期口服抗凝治疗
Age Ageing. 1988 Nov;17(6):388-96. doi: 10.1093/ageing/17.6.388.
6
Anticoagulant drugs in the elderly: the risks usually outweight the benefits.老年人使用抗凝药物:风险通常大于益处。
BMJ. 1988 Nov 12;297(6658):1261, 1263. doi: 10.1136/bmj.297.6658.1261.
7
Prospective evaluation of a flexible protocol for starting treatment with warfarin and predicting its maintenance dose.对华法林起始治疗灵活方案及预测其维持剂量的前瞻性评估。
Aust N Z J Med. 1989 Jun;19(3):191-7. doi: 10.1111/j.1445-5994.1989.tb00243.x.
8
The association of age with dosage requirement for warfarin.年龄与华法林剂量需求之间的关联。
Age Ageing. 1991 May;20(3):217-20. doi: 10.1093/ageing/20.3.217.
9
Age as a determinant of sensitivity to warfarin.年龄作为华法林敏感性的一个决定因素。
Br J Clin Pharmacol. 1977 Jun;4(3):315-20. doi: 10.1111/j.1365-2125.1977.tb00719.x.
10
Determinants of anticoagulant control in patients receiving warfarin.接受华法林治疗患者抗凝控制的决定因素。
Br J Clin Pharmacol. 1977 Jun;4(3):309-14. doi: 10.1111/j.1365-2125.1977.tb00718.x.

年龄对华法林抗凝诱导及维持的影响。

Effect of age upon the induction and maintenance of anticoagulation with warfarin.

作者信息

Gladman J R, Dolan G

机构信息

Department of Health Care of the Elderly, University Hospital, Nottingham, UK.

出版信息

Postgrad Med J. 1995 Mar;71(833):153-5. doi: 10.1136/pgmj.71.833.153.

DOI:10.1136/pgmj.71.833.153
PMID:7746774
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2398184/
Abstract

We aimed to examine the effect of age upon the control of anticoagulation with warfarin in ordinary clinical practice, using a retrospective examination of routine anticoagulation clinic records from the University Hospital, Nottingham. Considerable over-anticoagulation (international normalisation ratio (INR) > 6.0) during induction occurred in 54 (11%) of 495 patients and was more likely in older patients (p < 0.05). Lesser degrees of over-anticoagulation during induction (INR > 4.0) were also more common in older patients, occurring in 58% of those aged 75 or above. Loading doses of warfarin were not reduced in older patients. INR in the maintenance phase rose with age (p < 0.001) despite lower maintenance doses of warfarin (p < 0.001). An INR > 6.0 in the maintenance phase was noted in 24 (3%) of 739 patients and again was more likely in older patients (p < 0.05). Patients using ambulance transport to the clinic were older than those who did not (p < 0.01) and those aged over 75 had shorter intervals between clinic visits (p < 0.01). We conclude that doctors using warfarin therapy do not take sufficient account of the increased sensitivity of older people to warfarin. Hospital anticoagulant policies need implementation and evaluation.

摘要

我们旨在通过回顾诺丁汉大学医院常规抗凝门诊记录,研究年龄对普通临床实践中使用华法林进行抗凝控制的影响。495例患者中有54例(11%)在诱导期出现显著抗凝过度(国际标准化比值(INR)> 6.0),且老年患者更易出现(p < 0.05)。诱导期较低程度的抗凝过度(INR > 4.0)在老年患者中也更常见,75岁及以上患者中有58%出现这种情况。老年患者的华法林负荷剂量未降低。尽管华法林维持剂量较低(p < 0.001),但维持期INR随年龄增长而升高(p < 0.001)。739例患者中有24例(3%)在维持期出现INR > 6.0,同样老年患者更易出现(p < 0.05)。使用救护车前往门诊的患者比未使用的患者年龄更大(p < 0.01),75岁以上患者门诊就诊间隔时间更短(p < 0.01)。我们得出结论,使用华法林治疗的医生没有充分考虑老年人对华法林敏感性增加的问题。医院抗凝政策需要实施和评估。